pe
pep-04873 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (LPLPLL)

A small peptide that blocks ACE, the enzyme that raises blood pressure; studied as a possible blood-pressure treatment, experimental, not an approved drug.

statuscomputed targetACE length6 aa refs6
angiotensin-converting-enzyme-ace-inhibitors
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.837
pTM0.601
avg pLDDT90.5
ranking score0.891
STRUCTURE · PEP-04873 × ACE
ranking0.891
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence6 aa
156
LPLPLL
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.8369158506393433 boltz-2
ranking score 0.8912063837051392 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.946global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Leu-Pro-Leu-Pro-Leu-Leu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (LPLPLL) (pep-04873, v1). PeptideModel. https://peptidemodel.com/card/pep-04873
@peptide{pep04873,
  sequence = {LPLPLL},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 6 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use